Hanway Associates is proud to launch ‘The Social Impact of Cannabis Legalisation: How cannabis reform can shape lives, livelihoods and the law’.

This once-hypothetical scenario is fast becoming a reality. European cannabis reform has become a question of how, not if.

A ruling from the European Court of Justice (CJEU) opens up the French market for CBD, and sets the stage for a regulatory U-turn from the European Commission on novel foods.

Analysis of the proposed NZ cannabis referendum bill

With its wide array of uses, who should be regulating a substance with as many facets at CBD?

Debate about cannabis regulation cannot simply be a national one, but how can country-level reforms make way for international progress?

In a historic event that will be closely watched across the world, Canada today becomes the first G7 country to legalise cannabis for recreational use.

The UK government has laid historic new regulations rescheduling cannabis-based medicine, which will come into force on 1st November 2018.

The French Agency for Medicines and Healthcare Products Safety (ANSM) has published the list of the members who will make up the Special Committee charged with the review of medical cannabis benefits in France.

Hanway Associates CEO George McBride spoke at the Conservative Party Conference and Cannabis Invest UK this week on developments in the UK and European Cannabis industry.

On September 21st the UK government announced how they would define cannabis-based products for medicinal use. Following the conclusion of the two part review by the Chief Medical Officer and the ACMD on July 25th, Home Secretary Sajid Javid committed to swift action on the matter, and promised that these products would be lawful by autumn.

On Monday 10th September, the National Agency for Health and Medicines (ANSM) announced the creation of a special committee to review the evidence supporting the effectiveness of medical cannabis.

January 1st was a momentous day for the cannabis industry and drug policy reform globally. A week ago, when the clock struck midnight, California began legal sales of cannabis for adult use.

Despite cannabis being the most used illicit drug in the UK, little is known about the true scale of the UK cannabis market.

On October 24th 2017, Hanway Associates and Tantalus Labs submitted a document to British Columbia's Provincial Cannabis Secretariat.

The clock is ticking. Canadian provinces have less than a year in which to decide how, where and by whom cannabis will be sold.

Canada is set to legislate for sale of cannabis for responsible adult use before July 2018. The countdown starts now.

Blair Gibbs is a former UK government official who served as an advisor to the former Mayor of London Boris Johnson and the Justice Secretary Michael Gove. He is currently working in Vancouver.

Hanway Associates partner Dr Henry Fisher writing about 'Spice' in The Guardian

Into the Light is a white paper on Greenhouse cannabis cultivation in British Columbia by Hanway Associates, in collaboration with Tantalus Labs.